Literature DB >> 8806330

Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis.

A Greinacher, S Zinn, U W Birk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806330     DOI: 10.1016/s0140-6736(05)65684-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  [Thrombocytopathy and blood complications in uremia].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

2.  Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.

Authors:  Iván Palomo; Jaime Pereira; Marcelo Alarcón; Gonzalo Díaz; Patricia Hidalgo; Isabel Pizarro; Eric Jara; Patricio Rojas; Guillermo Quiroga; Rodrigo Moore-Carrasco
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Medical complications in hemodialysis patients requiring vascular access radiology procedures.

Authors:  Mary S Hammes
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

Review 4.  Heparin-induced thrombocytopenia: a renal perspective.

Authors:  Samaha Syed; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

5.  Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis.

Authors:  Yvette C Tanhehco; Adam Cuker; Michael Rudnick; Bruce S Sachais
Journal:  Thromb Res       Date:  2013-01-08       Impact factor: 3.944

6.  Fatal pulmonary embolism after hemodialysis vascular access declotting.

Authors:  Seyed-Ali Sadjadi; Maryam Sharif-Hassanabadi
Journal:  Am J Case Rep       Date:  2014-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.